We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of cancer therapy. The paper list is as follows:

“Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer”
by Abhenil Mittal, Consolacion Molto Valiente, Faris Tamimi, Ilana Schlam, Sarah Sammons, Sara M. Tolaney and Paolo Tarantino
Cancers 2023, 15(7), 2015; https://doi.org/10.3390/cancers15072015
Available online: https://www.mdpi.com/2072-6694/15/7/2015

“Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review”
by Celia García-Chico, Susana López-Ortiz, Saúl Peñín-Grandes, José Pinto-Fraga, Pedro L. Valenzuela, Enzo Emanuele, Claudia Ceci, Grazia Graziani, Carmen Fiuza-Luces, Simone Lista et al.
Cancers 2023, 15(1), 324; https://doi.org/10.3390/cancers15010324
Available online: https://www.mdpi.com/2072-6694/15/1/324

“The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited”
by Kevin Dzobo, Dimakatso A. Senthebane and Collet Dandara
Cancers 2023, 15(2), 376; https://doi.org/10.3390/cancers15020376
Available online: https://www.mdpi.com/2072-6694/15/2/376

“Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer”
by Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies and Rajesh Singh
Cancers 2023, 15(4), 1320; https://doi.org/10.3390/cancers15041320
Available online: https://www.mdpi.com/2072-6694/15/4/1320

“Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management”
by Chengjun Yao, Haiying Zhou, Yanzhao Dong, Ahmad Alhaskawi, Sohaib Hasan Abdullah Ezzi, Zewei Wang, Jingtian Lai, Vishnu Goutham Kota, Mohamed Hasan Abdulla Hasan Abdulla and Hui Lu
Cancers 2023, 15(4), 1077; https://doi.org/10.3390/cancers15041077
Available online: https://www.mdpi.com/2072-6694/15/4/1077

“Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer”
by Houssein Chhouri, David Alexandre and Luca Grumolato
Cancers 2023, 15(2), 504; https://doi.org/10.3390/cancers15020504
Available online: https://www.mdpi.com/2072-6694/15/2/504

“Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment”
by Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, Donald A. P. Brugman, Ulrike F. van Ark, Arwin S. Ramcharan, Paul W. Lebbink, Frederik J. H. Hoogwater, Daan G. Knapen, Derk Jan A. de Groot et al.
Cancers 2023, 15(7), 2119; https://doi.org/10.3390/cancers15072119
Available online: https://www.mdpi.com/2072-6694/15/7/2119

“Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches”
by Philip Posdzich, Christopher Darr, Thomas Hilser, Milan Wahl, Ken Herrmann, Boris Hadaschik and Viktor Grünwald
Cancers 2023, 15(2), 461; https://doi.org/10.3390/cancers15020461
Available online: https://www.mdpi.com/2072-6694/15/2/461

“MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities”
by Kang Qin, Lingzhi Hong, Jianjun Zhang and Xiuning Le
Cancers 2023, 15(3), 612; https://doi.org/10.3390/cancers15030612
Available online: https://www.mdpi.com/2072-6694/15/3/612

“Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer”
by Éabha O’Sullivan, Anna Keogh, Brian Henderson, Stephen P. Finn, Steven G. Gray and Kathy Gately
Cancers 2023, 15(6), 1635; https://doi.org/10.3390/cancers15061635
Available online: https://www.mdpi.com/2072-6694/15/6/1635

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office